Pharmafile Logo
Pharmafocus logo
Advanced Search
cdc1

Number of babies born with opioid dependence has tripled in US, says CDC report

August 12, 2016
Medical Communications, Research and Development CDC, addicted, babies, opioid dependence, opioids

A new report from the Centers for Disease Control and Prevention (CDC) has highlighted a sharp increase in the number …

News
allergan

Allergan set to acquire eye-care biotech ForSight VISION5

August 12, 2016
Medical Communications, Sales and Marketing Allergan, ForSight VISION5, acquisition, biotech, eye care

Allergan has announced its acquisition of privately-held, clinical-stage eye-care biotech ForSight VISION5 for a $95 million upfront payment and a …

News

Novartis admits employees gave kickbacks to doctors in South Korea

August 12, 2016
Medical Communications, Research and Development Novartis, kickbacks, south korea

Novartis has confirmed that six employees in South Korea gave kickbacks to doctors, as the current and former employees face …

News
laboratory-testing-az

Advaxis follows up Amgen deal with Phase IIa cancer trial success

August 12, 2016
Medical Communications, Research and Development Advaxis, immunotherapy. cancer. Amgen

Advaxis, a US biotech in cancer immunotherapy development, has announced that its lead immunotherapy product axalimogene filolisbac (AXAL) has hit …

News
gilead-sciences

Gilead to work with Genmab on HIV targeting technology

August 12, 2016
Medical Communications, Research and Development, Sales and Marketing Genmab, Gilead, HIV, duobody

Genmab has announced that it has entered into a collaboration deal with Gilead Sciences to use the DuoBody technology platform …

News
astrazeneca_building_white

Thousands to benefit with new anti-clotting drug recommendation, says NICE

August 12, 2016
Medical Communications, Sales and Marketing AstraZeneca, Brilique, ticagrelor

The National Institute for Health and Care Excellence (NICE) has published new draft guidance recommending AstraZeneca’s Brilique (ticagrelor) for people …

News
shutterstock_92671375

Valeant under criminal investigation

August 11, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Philidor, Valeant, investigation

Valeant Pharmaceuticals International is currently under investigation by the US attorney’s office in Manhattan over suspicions that the firm intentionally …

News

FDA accepts Marathon’s Duchenne drug for priority review

August 11, 2016
Research and Development, Sales and Marketing Duchenne Muscular Dystrophy, FDA, deflazacort, marathon, marathon pharmaceuticals

Marathon Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has accepted and granted a priority review for …

News
chemo-web

Heron Therapeutics gets FDA approval for chemotherapy-induced nausea drug

August 11, 2016
Research and Development, Sales and Marketing FDA, chemotherapy-induced nausea, granisetron, heron therapeutics, sustol

Heron Therapeutics has announced that it has received US Food and Drug Administration (FDA) approval for Sustol (granisetron) for the …

News
chronos_therapeutics

Chronos Therapetics strengthens management with two new vice presidents

August 10, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Private biotech Chronos Therapeutics has announced two new additions to its management team; Dr Fraser Murray and Dr Timonthy Schulz-Utermoehl …

Appointment
josh-smiley

New senior VP, finance at Eli Lilly

August 10, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly

Eli Lilly has announced that Joshua Smiley is set to become senior vice president, finance, and treasurer from October 1, …

Appointment
china-pharmaceutical-industry

New Agilent expansion will ‘more than double’ nucleic acid API manufacture

August 10, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Agilent, expansion, manufacturing, oligonucleotide

Agilent Technologies is set to expand its pharmaceutical manufacturing operations with a 20-acre facility in Weld County, Colorado. The facility …

News
lilly_corporate_hq

Interim analysis fails to show benefits for Lilly’s abemaciclib in advanced breast cancer

August 10, 2016
Research and Development Eli Lilly, abemaciclib, breast cancer

Eli Lilly has announced that, after a pre-planned interim analysis for their Phase III MONARCH2 trial, investigators have decided to …

News
shutterstock_138095450

Valeant stock rises despite weak Q2 results

August 10, 2016
Research and Development, Sales and Marketing Valeant, financial results

Valeant Pharmaceuticals’ share price in pre-market trading has risen 7.44% to $24.12 in the wake of its Q2 results announcement. …

News
biogen_austria_238

Biogen names haemophilia spin-off Bioverativ

August 10, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Biogen, bioverativ

Biogen has announced that Bioverativ will be the name of the standalone spin-off of its haemophilia and other blood disorders …

News

Experimental stem cell treatment shows promise in rheumatoid arthritis

August 10, 2016
Research and Development Mesoblast, rheumatoid arthritis, stem cell treatment

Mesoblast has announced results from a Phase II clinical trial evaluating MPC-300-IV in patients with biologic refractory rheumatoid arthritis (RA) …

News
takeda_tokyo_hq

Old CDF drug not recommended in initial NICE guidance due to lack of evidence

August 10, 2016
Research and Development, Sales and Marketing Adcetris, Cancer Drugs Fund, NICE, Takeda, hodgkin's lymphoma

The National Institute for Health and Care Excellence (NICE) has published draft guidance not recommending Takeda’s Adectris (brentuximab vedotin), despite …

News
imlygic_amgen

NICE recommends Amgen’s Imlygic for advanced skin cancer

August 9, 2016
Manufacturing and Production, Sales and Marketing Amgen, Imlygic, NICE, skin cancer

NICE has published its final draft guidance recommending Amgen’s Imlygic (talimogene laherparepvec) for the treatment of advanced melanoma in adults …

News
pharma_pill_manufacturing

Helsinn and MEI Pharma join forces to develop leukaemia drug Pracinostat

August 9, 2016
Manufacturing and Production, Research and Development Helsinn, MEI Pharma, Pracinostat, chronic myeloid leukaemia

Swiss pharmaceutical group Helsinn has entered an agreement with MEI Pharma over the licensing, development and commercialisation of Pracinostat (SB939) …

News
ema_inside

New therapy wins EMA orphan drug designation for ALS

August 9, 2016
Manufacturing and Production, Research and Development EMA, Ice Bucket Challenge, ab science, als, masitinib, oprhan drug designation

French pharma company AB Science has announced that the European Medicines Agency has granted orphan drug status to masitinib for …

News
The Gateway to Local Adoption Series

Latest content

Ofichem brings all brands under single trading name

April 23, 2026

Carvolix strengthens its Board of Directors, advisory board and governance structure

April 23, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

April 22, 2026

Incyclix Bio announces new additions to the Board

April 22, 2026

Remedy Plan Therapeutics Appoints Jotin Marango as CFO and CBO

April 21, 2026